New symptomatic strategies in Alzheimer's disease

Practice parameter: Management of dementia (an evidence-based review) [RETIRED]

Rachelle S. Doody, J E Stevens, C. Beck et al. · Neurology · 2001 · 1.7K citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial

The Lancet · 2004 · 896 citations

Medicine, Pharmacology, Pharmacotherapy +14

The 5-HT6 Receptor Antagonist SB-271046 Selectively Enhances Excitatory Neurotransmission in the Rat Frontal Cortex and Hippocampus

Lee A. Dawson · Neuropsychopharmacology · 2001 · 237 citations · Full text

Life Sciences, Neuroscience, Pharmacology +12

Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease

Alexandra Potter, June Corwin, Jason E. Lang et al. · Psychopharmacology · 1999 · 163 citations

Life Sciences, Neuroscience, Pharmacology +16

5‐HT₆ receptor antagonist SB‐271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex

Laurent Lacroix, Lee A. Dawson, Jim J. Hagan et al. · Synapse · 2003 · 144 citations

Life Sciences, Neuroscience, Pharmacology +17